Anurag Relan Selected Research

Hereditary Angioedemas

4/2021	Recombinant human C1 esterase inhibitor for hereditary angioedema attacks: A European registry.
1/2021	Population pharmacokinetics of recombinant human C1 esterase inhibitor in children with hereditary angioedema.
11/2019	Safety of recombinant human C1 esterase inhibitor for hereditary angioedema attacks during pregnancy.
1/2019	Recombinant human C1 esterase inhibitor treatment for hereditary angioedema attacks in children.
9/2018	Efficacy of recombinant human C1 esterase inhibitor across anatomic locations in acute hereditary angioedema attacks.
11/2017	Recombinant human C1 esterase inhibitor for acute hereditary angioedema attacks with upper airway involvement.
11/2017	Efficacy of recombinant human C1 esterase inhibitor for the treatment of severe hereditary angioedema attacks.
1/2017	Sustained response of recombinant human C1 esterase inhibitor for acute treatment of hereditary angioedema attacks.
5/2015	Recombinant human-C1 inhibitor is effective and safe for repeat hereditary angioedema attacks.
4/2013	Immunosafety of recombinant human C1-inhibitor in hereditary angioedema: evaluation of ige antibodies.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Anurag Relan Research Topics

Disease

10	Hereditary Angioedemas 04/2021 - 04/2013
5	Hypersensitivity (Allergy) 01/2019 - 04/2013
3	Anaphylaxis (Anaphylactic Shock) 09/2017 - 04/2013
2	Lymphadenopathy 10/2023 - 01/2023
2	Infections 10/2023 - 01/2023
1	Bronchiectasis 01/2023
1	Lymphoma (Lymphomas) 01/2023
1	Fatigue 09/2017
1	Headache (Headaches) 09/2017
1	Hemorrhage 01/2016
1	Angioedema 01/2016
1	Acquired angioedema 01/2012

Drug/Important Bio-Agent (IBA)

12	Complement C1 Inhibitor Protein (C1 Esterase Inhibitor)IBA 04/2021 - 01/2012
3	AntibodiesIBA 09/2017 - 04/2013
2	leniolisibIBA 10/2023 - 01/2023
2	Phosphatidylinositols (Phosphatidylinositol)IBA 10/2023 - 01/2023
2	Neutralizing AntibodiesIBA 01/2019 - 02/2014
1	Immunoglobulins (Immunoglobulin)IBA 10/2023
1	Kallikreins (Kallikrein)IBA 01/2016
1	Complement System Proteins (Complement)IBA 01/2016
1	BradykininIBA 01/2016
1	Factor XIIa (Coagulation Factor XIIa)IBA 01/2016
1	Immunoglobulin E (IgE)IBA 04/2013
1	Blood Proteins (Serum Proteins)IBA 01/2012

Therapy/Procedure

1	Therapeutics 10/2023